These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24125562)

  • 1. Psychometric properties of the Italian version of the Scales for Outcomes in Parkinson's disease- Cognition (SCOPA-Cog).
    Isella V; Mapelli C; Morielli N; De Gaspari D; Siri C; Pezzoli G; Antonini A; Poletti M; Bonuccelli U; Picchi L; Napolitano A; Vista M; Veglia M; Piamarta F; Grassi F; Appollonio IM
    Funct Neurol; 2013; 28(2):121-5. PubMed ID: 24125562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric attributes of the SCOPA-COG Brazilian version.
    Carod-Artal FJ; Martínez-Martin P; Kummer W; Ribeiro Lda S
    Mov Disord; 2008 Jan; 23(1):81-7. PubMed ID: 17987646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Psychometric attributes of Scales for Outcomes in Parkinson's Disease-Cognition (SCOPA-Cog), Castilian language].
    Martínez-Martín P; Frades-Payo B; Rodríguez-Blázquez C; Forjaz MJ; de Pedro-Cuesta J;
    Rev Neurol; 2008 Oct 1-15; 47(7):337-43. PubMed ID: 18841543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric properties of the SCOPA-AUT Brazilian Portuguese version.
    Carod-Artal FJ; Ribeiro Lda S; Kummer W; Martinez-Martin P
    Mov Disord; 2010 Jan; 25(2):205-12. PubMed ID: 19938162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addenbrooke's Cognitive Examination validation in Parkinson's disease.
    Reyes MA; Perez-Lloret S; Roldan Gerschcovich E; Martin ME; Leiguarda R; Merello M
    Eur J Neurol; 2009 Jan; 16(1):142-7. PubMed ID: 19049504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Psychometric attributes of the Parkinson's Disease-Cognitive Rating Scale. An independent validation study].
    Martínez-Martín P; Prieto-Jurczynska C; Frades-Payo B
    Rev Neurol; 2009 Oct 16-31; 49(8):393-8. PubMed ID: 19816841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
    Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
    Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should the SCOPA-COG be modified? A Rasch analysis perspective.
    Forjaz MJ; Frades-Payo B; Rodriguez-Blazquez C; Ayala A; Martinez-Martin P;
    Eur J Neurol; 2010 Feb; 17(2):202-7. PubMed ID: 19832901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-cultural adaptation and psychometric properties of the SCOPA-Sleep-German version.
    Goebel S; Steinmann E; Leplow B; Mehdorn HM
    Neurol Sci; 2018 Jul; 39(7):1225-1230. PubMed ID: 29656379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of possible mild cognitive impairment in Parkinson's disease: validity of the SCOPA-Cog.
    Isella V; Mapelli C; Morielli N; Siri C; De Gaspari D; Pezzoli G; Antonini A; Poletti M; Bonuccelli U; Picchi L; Napolitano A; Vista M; Appollonio IM
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1160-3. PubMed ID: 24011719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease.
    Martinez-Martin P; Rodriguez-Blazquez C; Abe K; Bhattacharyya KB; Bloem BR; Carod-Artal FJ; Prakash R; Esselink RA; Falup-Pecurariu C; Gallardo M; Mir P; Naidu Y; Nicoletti A; Sethi K; Tsuboi Y; van Hilten JJ; Visser M; Zappia M; Chaudhuri KR
    Neurology; 2009 Nov; 73(19):1584-91. PubMed ID: 19901251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metric properties of the mini-mental Parkinson and SCOPA-COG scales for rating cognitive deterioration in Parkinson's disease.
    Serrano-Dueñas M; Calero B; Serrano S; Serrano M; Coronel P
    Mov Disord; 2010 Nov; 25(15):2555-62. PubMed ID: 20824734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Clinical Impression of Severity Index for Parkinson's Disease: international validation study.
    Martínez-Martín P; Rodríguez-Blázquez C; Forjaz MJ; de Pedro J;
    Mov Disord; 2009 Jan; 24(2):211-7. PubMed ID: 18973256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Korean Version of the Scales for Outcomes in Parkinson's Disease-Sleep.
    Sung YH; Kim HJ; Koh SB; Kim JS; Kim SJ; Cheon SM; Cho JW; Kim YJ; Ma HI; Park MY; Baik JS; Lee PH; Chung SJ; Kim JM; Song IU; Kim HJ; Kim JY; Kwon DY; Lee JH; Lee JY; Kim JS; Yun JY; Hong JY; Kim MJ; Youn J; Kim JS; Oh ES; Yang HJ; Yoon WT; You S; Kwon KY; Park HE; Lee SY; Kim Y; Kim HT; Ahn TB
    J Korean Med Sci; 2018 Jan; 33(2):e14. PubMed ID: 29215823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability, validity, and diagnostic accuracy of Parkinson's Disease-Cognitive Rating Scale in Iranian patients with idiopathic Parkinson's disease.
    Mahmoudi Asl A; Mehdizadeh M; Kulisevsky J; Sabet A; Taghavi Azar Sharabiani P; Mehdizadeh H; Ashayeri H; Taghizadeh G
    Disabil Rehabil; 2022 May; 44(10):2091-2098. PubMed ID: 32924645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the Validity and Reliability of the Korean Version of the Scales for Outcomes in Parkinson's Disease-Cognition.
    Park J; Oh E; Koh SB; Song IU; Ahn TB; Kim SJ; Cheon SM; Kim YJ; Cho JW; Ma HI; Park MY; Baik JS; Lee PH; Chung SJ; Kim JM; Kim HJ; Sung YH; Kwon DY; Lee JH; Lee JY; Kim JS; Yun JY; Kim HJ; Hong JY; Kim MJ; Youn J; Yang HJ; Yoon WT; You S; Kwon KY; Lee SY; Kim Y; Kim HT; Kim JS; Kim JY
    J Mov Disord; 2024 Jul; 17(3):328-332. PubMed ID: 38566308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive impairment in Parkinson's disease.
    Verbaan D; Marinus J; Visser M; van Rooden SM; Stiggelbout AM; Middelkoop HA; van Hilten JJ
    J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1182-7. PubMed ID: 17442759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psychometric attributes of the Scales for Outcomes in Parkinson's Disease-Psychosocial (SCOPA-PS): validation in Spain and review].
    Martínez-Martín P; Carroza-García E; Frades-Payo B; Rodríguez-Blázquez C; Forjaz MJ; de Pedro-Cuesta J;
    Rev Neurol; 2009 Jul 1-15; 49(1):1-7. PubMed ID: 19557692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of cognition in Parkinson's disease.
    Marinus J; Visser M; Verwey NA; Verhey FR; Middelkoop HA; Stiggelbout AM; van Hilten JJ
    Neurology; 2003 Nov; 61(9):1222-8. PubMed ID: 14610124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent validation of the scales for outcomes in Parkinson's disease-autonomic (SCOPA-AUT).
    Rodriguez-Blazquez C; Forjaz MJ; Frades-Payo B; de Pedro-Cuesta J; Martinez-Martin P;
    Eur J Neurol; 2010 Feb; 17(2):194-201. PubMed ID: 19780808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.